Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II-III Non-small Cell Lung Cancer”

432 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 432 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02595944
What this trial is testing

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 903
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Not applicableStudy completedNCT01346280
What this trial is testing

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)Colon Cancer (Stage II &Amp; III)Rectal Cancer (Stage III)
National Cancer Institute (NCI) 1,079
Not applicableLooking for participantsNCT06122064
What this trial is testing

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8+1 more
Mayo Clinic 100
Large-scale testing (Phase 3)Study completedNCT00004011
What this trial is testing

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 354
Testing effectiveness (Phase 2)Study completedNCT02473133
What this trial is testing

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Centre Henri Becquerel 158
Testing effectiveness (Phase 2)UnknownNCT05177497
What this trial is testing

SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC

Who this might be right for
NSCLC, Stage III
Shanghai Chest Hospital 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05306847
What this trial is testing

Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Peking Union Medical College Hospital 93
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999710
What this trial is testing

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung CancerNsclc+2 more
Memorial Sloan Kettering Cancer Center 61
Testing effectiveness (Phase 2)UnknownNCT01683175
What this trial is testing

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer Stage III
Tianjin Medical University Cancer Institute and Hospital 94
Not applicableEnded earlyNCT00881712
What this trial is testing

Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)

Who this might be right for
Non-Small Cell Lung Cancer
University of Florida 15
Testing effectiveness (Phase 2)UnknownNCT00616031
What this trial is testing

Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Kyoto University 150
Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Looking for participantsNCT05398094
What this trial is testing

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage IIIKRAS P.G12C
Fundación GECP 19
Large-scale testing (Phase 3)Study completedNCT00006229
What this trial is testing

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 774
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00003037
What this trial is testing

Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03693300
What this trial is testing

Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 117
Testing effectiveness (Phase 2)Looking for participantsNCT06617936
What this trial is testing

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Who this might be right for
Unresectable Non-small Cell Lung Cancer
Hua Zhang 36
Load More Results